Both interventions significantly suppressed tumor growth, as evidenced by reduced gut width, decreased Yki-GFP signal, and lower mitotic (pH3+) cell counts (Fig. 4c–f and Extended Data Fig. 3b–i). The gene discussed is YAP1; the disease is neoplasm.